CI - Cigna Corporation
149.75 +1.76 (1.19%)
Pre-Market: 8:30AM EDT
| Previous Close | 149.00 |
| Open | 149.51 |
| Bid | 146.30 x 800 |
| Ask | 149.75 x 800 |
| Day's Range | 147.74 - 151.72 |
| 52 Week Range | 141.95 - 226.61 |
| Volume | 2,346,701 |
| Avg. Volume | 2,907,851 |
| Market Cap | 56.245B |
| Beta (3Y Monthly) | 1.03 |
| PE Ratio (TTM) | 14.04 |
| EPS (TTM) | 10.54 |
| Earnings Date | May 2, 2019 |
| Forward Dividend & Yield | 0.04 (0.02%) |
| Ex-Dividend Date | 2019-03-08 |
| 1y Target Est | 238.95 |
- Zacks•57 minutes ago
Top 5 ROE Stocks to Buy on Better-Than-Expected Q1 Earnings
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
- GuruFocus.com•13 hours ago
The 5 Worst-Performing Health Insurance Stocks
So far in 2019, the health care sector is the most underperforming sector. These insurance stocks have declined the most
- Business Wire•19 hours ago
Ryan Kocher Named President for Cigna's Business in Pacific Northwest Markets
Cigna (CI) has named Ryan Kocher as president for its health care and related benefits plans in the Pacific Northwest market, which includes the states of Washington, Oregon, Idaho and Alaska. Kocher joined Cigna in 2003 and most recently was the chief operating officer for the company’s MidSouth market, which comprises Tennessee, Arkansas, Kentucky and Mississippi. Prior to that he held a series of increasingly responsible positions in sales, account management and underwriting throughout Cigna's Southeast region.
- Zacks•5 days ago
Stock Market News For Apr 18, 2019
Wall Street closed lower on Wednesday as stiff loses of the healthcare sector negated the positive impact of strong first quarter earnings results.
- Zacks•5 days ago
Medicare-for-All, Mueller Report Spell Danger: 5 Utility Picks
Superior dividend yields and steady revenues make utilities good choices in tough times.
- Barrons.com•5 days ago
‘Goodwill’ Write-Offs Are an Earnings Killer. How to Spot Trouble Coming.
Companies write off “goodwill” when the value of acquired assets declines. It happened at Kraft Heinz and GE. Keep an eye on Bayer and Cigna next.
- GuruFocus.com•6 days ago
Keeley Funds' Mid Cap Dividend Value Fund 1st Quarter Commentary
For the quarter ended March 31, 2019, the KEELEY Mid Cap Dividend Value Fund's net asset value ("NAV") per Class A share rose 13.67% compared with a 14.37% gain for the Russell Mid Cap Value Index. Warning! GuruFocus has detected 2 Warning Signs with VMI. Brixmor Property Group (BRX - $18.37 - NYSE) (BRX) is a real estate investment trust that owns and operates grocery-anchored shopping centers.
Associated Press•6 days agoMarkets Right Now: Stocks end lower as insurers fall
The latest on developments in financial markets (all times local): 4:00 p.m. Stocks are closing lower on Wall Street Wednesday as losses by health care companies outweigh gains elsewhere in the market. ...
- MarketWatch•6 days ago
Health-care stocks are down in early Wednesday trade, led by Anthem, Cigna and UnitedHealth
Health-care stocks continued to fall on Wednesday morning, led by Anthem Inc. , Cigna Corp. and UnitedHealth Group Inc. The Health Care Select Sector SPDR Fund was down 1.5% in early intraday trade. Companies in the managed care and health services sectors are facing "temporary downside risk," thanks to the Medicare-for-all debate, analysts at J.P. Morgan wrote in a note to clients Tuesday. UnitedHealth reported earnings on Tuesday that beat expectations, but shares still fell, a possible indication of investors' anxiety over U.S. Sen. Bernie Sanders' latest Medicare-for-all proposal. The Health Care Select Sector SPDR Fund has been lagging the market in recent months, gaining 1.2% in the year to date. The S&P 500 has gained 16% and the Dow Jones Industrial Average has gained 13.4%.
- Market Realist•6 days ago
ANTM or CI: Comparing Cash Flows and Capital Investments in 2019
Anthem or Cigna: Which Is the Better Pick in April?(Continued from Prior Part)Cash flow projections On its fourth-quarter earnings conference call, Anthem guided for operating cash flows of more than $5.2 billion in 2019, a YoY (year-over-year) rise
- Investopedia•6 days ago
Why ‘Scared’ Investors May Push Health Care Stocks Even Lower
While the broad market zooms ahead, health care stocks are being weighed down by regulatory threats even as earnings forecasts remain strong.
- Reuters•7 days ago
UnitedHealth sees minimal impact from rebate system overhaul
Shares of the company fell 4 percent and dragged down those of rivals Anthem Inc, Centene Corp, Humana Inc and Cigna Corp. "It goes back to the political pressure on the managed care area," Thomas Martin, senior portfolio manager at GLOBALT Investments in Atlanta said. The healthcare sector has come under pressure after the U.S. government in January proposed a rule that would overhaul the use of drug company rebates in government-run healthcare plans.
- Investor's Business Daily•7 days ago
Insurance Stocks Sink As UnitedHealth Warns On Medicare For All
UnitedHealth, the nation's largest insurer, topped Q1 earnings views, but shares turned negative on "Medicare for All" fears.
- InvestorPlace•7 days ago
5 Healthcare Stocks to Watch If America Chooses a Single-Payer System
Even for the brightest among us, our current healthcare system is a convoluted mess that's difficult to fully understand. With terms like HMOs, PPOs and PFPMs, searching for the right coverage is often as desirable as doing your taxes. However, a political movement to simplify the system has serious implications for you and your portfolio (via healthcare stocks).Earlier this week, Senator Bernie Sanders explained his ambitious plan for a single-payer healthcare system. Broadly, what this entails is that all Americans will enjoy comprehensive health coverage. Under his "Medicare for All Act," patients won't have to pay out of pocket for doctor visitations. It has raised eyebrows because the proposal is considerably more generous than other single-payer countries.Even more startling for both supporters and opponents, Sanders' plan has generated significant support. In particular, presidential candidates Elizabeth Warren, Cory Booker, Kamala Harris and Kirsten Gillibrand cosponsored the bill. With momentum rising, so too has the importance for healthcare stocks to watch.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOne of the striking components of Sanders' plan is its scope. If it passes, all invoices will eventually go to the federal government. Theoretically, this approach does away with some of the volatile pricing imposed within the current system. But such pricing changes would severely impact healthcare stocks.Another sticking point regarding this comprehensive proposal is a possible existential crisis. In many ways, healthcare stocks exist because our broader medical umbrella is so convoluted. Plus, pharmaceuticals can radically hike drug prices, knowing that insurers and patients have little recourse. * 7 Stocks to Buy for Spring Season Growth Of course, paying for a new system would require a substantial tax influx. Sanders hasn't provided a convincing financial plan to accommodate his bill. Nevertheless, the current political environment suggests a change is coming. Here are five healthcare stocks to watch, just in case. UnitedHealth Group (UNH)Source: Shutterstock On Thursday, shares of UnitedHealth Group (NYSE:UNH) tumbled over 4%, and I can't say that I'm surprised. Sure, the commonly cited explanation for why UNH stock took a hit was an analyst downgrade. But the reality is that among healthcare stocks to watch, insurance providers suffer the most risk.Naturally, the Medicare for All Act weighs heavily on UNH stock. Insurers thrive on both the complexity of our healthcare system and the necessity for it. Going without insurance just isn't smart, considering the likelihood of a catastrophic event or disease. According to a shocking BBC report last year, cancer is rising everywhere, including in developed nations.Moreover, fighting that awful disease isn't cheap, with average treatments running well into six digits. The threat of financial ruin is enough for people to run to insurance companies. But with government-endorsed mandated coverage, it's unclear how for-profit insurers like UNH stock can thrive. Cigna (CI)Source: Shutterstock Also on Thursday, shares of Cigna (NYSE:CI) fell sharply, losing 2.5%. Again, I'm not surprised. Compared to other healthcare stocks to watch, CI stock faces an existential threat. If the Medicare for All Act passes, it has severe implications for the insurance company.As we discussed, Sanders' plan is incredibly comprehensive. In his vision of a covered America, no one reaches into their wallets. Whether you're seeing a doctor, getting your teeth cleaned at the dentist's office, or trying on a new pair of eyeglasses, sticker shock in this arena will be obsolete. * 10 S&P 500 Stocks to Weather the Earnings Storm Of course, the problem is that CI stock thrives on this sticker shock. When you cut through all the corporate BS, you realize that the insurance industry prospers on fear. But a government-mandated coverage plan eliminates that fear with a safety net. Thus, I'm currently hesitant on Cigna, and other insurance-related healthcare stocks. Pfizer (PFE)Source: Kojach Via FlickrAlthough insurance companies present an easy target in light of recent political developments, pharmaceuticals can't dodge the bullet, either. Investors and especially current shareholders of Pfizer (NYSE:PFE) should adopt a very cautious stance. On Thursday, PFE stock dipped more than 1%.As with the first two healthcare stocks to watch, Pfizer's pensive trading isn't surprising. In prior generations, a rising tide lifted all boats. But in the next few years, a receding tide could strand everyone. That might be the case for PFE stock, and similar rivals in the pharmaceutical space.As the controversy surrounding the "pharma bro" incident revealed, pharmaceuticals can get away with charging ridiculous prices. But with the Medicare for All Act, that type of predatory behavior -- or even robust capitalism -- stops. When you have to answer to the federal government, suddenly, everyone plays nice.That's great for patients, but not so much for PFE stock. Boston Scientific (BSX)Source: Boston Scientific Ordinally, I wouldn't issue a cautionary note on Boston Scientific (NYSE:BSX). As one of the world's premiere medical-equipment providers, BSX stock represents a life-saving investment. Plus, shares have generally performed well following the aftermath of the Great Recession.Unfortunately, that might change in the coming years, especially if the Medicare for All Act passes. Similar to the plight of other medical stocks to watch, Boston Scientific absorbed a noticeable 1% decline on Thursday. That's just the beginning if the worst-case scenario occurs. * 10 Dividend Growth Stocks You Can't Miss Primarily, BSX stock will essentially lose out on a free market. Instead, a government-imposed network will dictate product pricing and other core details. Essentially, this eliminates the profit motive for Boston Scientific. Since many developed countries have some sort of single-payer system, BSX must cope with the loss of a viable partner. HCA Healthcare (HCA)Source: Shutterstock On surface level, HCA Healthcare (NYSE:HCA) should be one of the healthcare stocks to watch…for a positive reason. Following the end of the Obama administration, Gallup reported a conspicuous rise in the number of uninsured Americans. But under Medicare for All, the insured will likely represent a surge in demand for HCA stock.That's a strong benefit, but it's probably not a net benefit. I say this because the markets really punished HCA stock on Thursday, dropping it down nearly 3%. The most common explanation is that the rest of the sector was also volatile. If other segments within the healthcare industry falls, so too will HCA.But the overriding factor behind the single-payer proposal is big government. So even if the uninsured flock to hospitals and clinics, they can't adopt capitalistic pricing. Instead, the feds will oversee everything, ensuring everyone has access to equal and "fair" healthcare.It's a great deal for patients, but not so much for hospitals, or anyone in this industry for that matter.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * FAANNG Stocks, Ranked From Cheapest to Most Expensive * 7 Stocks With a Lot on the Line This Earnings Season * 7 Marijuana Companies: Which Pot Stocks Should You Buy? Compare Brokers The post 5 Healthcare Stocks to Watch If America Chooses a Single-Payer System appeared first on InvestorPlace.
- Benzinga•7 days ago
ReWalk Robotics Higher After First Cigna Insurance Beneficiary Receives Personal 6.0 Exoskeleton
ReWalk said a Cigna Corp (NYSE: CI) insurance beneficiary in New York became eligible to receive its ReWalk Personal 6.0 exoskeleton. The person had suffered a spinal cord injury in a motorcycle accident in 2016. Cigna revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury in February after having a non-coverage policy previously.
Market Realist•7 days agoANTM or CI: Comparing Tax Rates and Interest Expenses in 2019
Anthem or Cigna: Which Is the Better Pick in April?(Continued from Prior Part)Tax rate projectionsIn its fourth-quarter earnings press release, Anthem (ANTM) guided for a 2019 effective tax rate in the range of 19.5%–21.5%, a YoY (year-over-year)
Motley Fool•8 days ago3 Top Large-Cap Stocks to Buy in April
The market has started serving up potential bargains among big company stocks.
- GuruFocus.com•8 days ago
52-Week Company Lows
According to GuruFocus' list of 52-week lows, these guru stocks have reached their 52-week lows. The price of UnitedHealth Group Inc. (UNH) shares has declined to close to the 52-week low of $223.22, which is 23.3% off the 52-week high of $287.94. The company has a market cap of $214.19 billion.
- Market Realist•8 days ago
What Are Analysts Recommending for ANTM and CI?
Anthem or Cigna: Which Is the Better Pick in April?Stock price movementsOn April 12, Anthem (ANTM) closed at $252.85, 8.48% lower than its previous closing price, 14.95% higher than its 52-week low of $219.96, and 20.48% lower than its 52-week high
- InvestorPlace•8 days ago
There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
April started poorly for Walgreens Boots Alliance (NASDAQ: WBA). A weak second-quarter earnings report sent Walgreens stock down 12.8% on April 2. With a downtrend very clearly in place, why should investors even consider WBA stock after the plunge?Source: Mike Mozart via FlickrWalgreens reported non-GAAP earnings of $1.64 as revenue grew 4.6% to $34.53 billion. A confluence of negative headwinds hit the company's bottom line. Higher reimbursement pressures, lower generic deflation, lower brand inflation and weak performance from restructuring programs led to the poor results. * 7 Marijuana Companies: Which Pot Stocks Should You Buy? Markets now know why Walgreens, along with CVS (NYSE: CVS) and Rite Aid (NYSE: RAD) fell ahead of the results report. Markets even sold off health care plan stocks like Cigna (NYSE: CI) and Humana (NYSE: HUM) in 2019: there are significant market-wide headwinds.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Long-Term Growth and Walgreens StockWalgreens has four strategic priorities aimed at delivering sustainable, long-term growth. It is accelerating the company's digital footprint, transforming its approach to retail, creating neighborhood health destinations, and implementing a revamped cost management program.This jargon on cost reduction will not mean much to the shareholder who just lost 12.8%.To stabilize the business as reimbursement pressures worsen, Walgreens must improve same-store sales. The near-term problems in achieving growth here are the acquired Rite Aid stores. Sales grew 7.3% and organic sales grew 1.6% but adjusted growth profit declined a substantial 3.5% in the quarter. Pharmacy and retail both fell. Gross margin from Pharmacy fell 260 basis points.A 6.8% drop in SG&A spend, along with cost savings initiatives ahead may slow the weakening operating income, which fell 11.9% in the second quarter. Opportunity and Walgreens StockA weaker cough, cold, and flu season added to Walgreens' woes but could create an opportunity for value investors. Since results were so weak, Walgreens could move up from here if management moves swiftly to balance its operating expenses against the higher reimbursement pressure.Digitization will help Walgreens increase its efficiency but it needs more than that. Still, bringing in the Microsoft (NASDAQ: MSFT) Teams to consolidate its internal digital team under a Chief Digital Officer will improve back-office efficiency.Walgreens restructured management such that there are two teams in development and delivery. One accomplishment is that its 5-star rated app has 55 million downloads. Another is it has 85 million active Balance Rewards members. The drug store clearly has the potential to reach out to its customer base through the mobile app. What is not clear yet is how much more business the app will bring for Walgreens. Near-term OutlookThe weak current third quarter for Walgreens will follow with improvements in Q4. While investors are disturbed by management's realistic goal-setting of mid-to-high single-digit growth, the reset in expectations creates an entry point for value investors.Plus, with the company working to offset the generic impact by 50% - 60%, profit margins may start to stabilize. Overall, it plans to cut costs by $1.5 billion. That is a substantial number and will benefit the company's long-term health.Walgreens will also shift its resources towards growing its Health & Beauty segment where it is confident that it can win an already very attractive business. The Bottom Line on Walgreens StockThe analyst positional changes are mixed. According to Tipranks, one analyst called WBA stock a "sell" while six have a "hold" and two analysts have a "buy." The average price target is $61 a share, which suggests the stock has an upside of 11%.Patient investors may want to wait for the selling-pressure to ease for a few days. Walgreens is already trading at a discount but this could widen. Still, even though drug store stocks are out of favor, Walgreens is the strongest of the available picks.Disclosure: As of this writing, the author did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post There's a Buy the Dip Opportunity in Walgreens Stock but It Isn't Now appeared first on InvestorPlace.
- MarketWatch•11 days ago
Here’s how Bernie Sanders says he would fund ‘Medicare for All’
Sen. Bernie Sanders knows there’s an uphill challenge convincing Americans they could afford a government-run health insurance program, so with the introduction of a new Medicare for All bill, he included financing options.
Associated Press•11 days agoAsian stocks mostly higher after mixed Wall Street day
Asian stock markets were mostly higher Friday after a mixed Wall Street close on listless trading. Benchmarks in Tokyo, Sydney and Seoul rose. China's main index was up 1 point while Hong Kong retreated. ...
- Business Wire•12 days ago
Cigna Corporation’s First Quarter 2019 Earnings Release Details
Global health service company Cigna Corporation will release its first quarter 2019 financial results on Thursday, May 2, 2019 and will host a conference call on the same day.
